Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06784414
What this trial is testing

Analysis of Risk Factors for Recurrence of Periprosthetic Infection in Megaprostheses Implanted for Sarcoma of Bone

Who this might be right for
PJI
IRCCS Azienda Ospedaliero-Universitaria di Bologna 22
Testing effectiveness (Phase 2)Looking for participantsNCT06684327
What this trial is testing

Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

Who this might be right for
Paget Disease, ExtramammaryRhabdomyosarcomaTesticular Cancer+2 more
Fudan University 100
Not applicableLooking for participantsNCT06753136
What this trial is testing

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Who this might be right for
Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more
Istituto Oncologico Veneto IRCCS 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686367
What this trial is testing

Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers

Who this might be right for
Metastatic Myxoid LiposarcomaMetastatic Synovial SarcomaUnresectable Myxoid Liposarcoma+1 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00520936
What this trial is testing

Pemetrexed in Children With Recurrent Cancer

Who this might be right for
OsteosarcomaMedulloblastomaSarcoma, Ewing's+6 more
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT06816771
What this trial is testing

Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents

Who this might be right for
Rhabdomyosarcoma, Recurrent, Refractory
Shandong Cancer Hospital and Institute 38
Testing effectiveness (Phase 2)Looking for participantsNCT06905132
What this trial is testing

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Medical University of South Carolina 40
Testing effectiveness (Phase 2)Ended earlyNCT02207309
What this trial is testing

Pazopanib Maintenance Phase II

Who this might be right for
Sarcoma
Ludwig-Maximilians - University of Munich 1
Not applicableNo Longer AvailableNCT02712567
What this trial is testing

SARC021C: A Continuation Study of TH-CR-406/SARC021

Who this might be right for
Soft Tissue Sarcoma
Sarcoma Alliance for Research through Collaboration
Testing effectiveness (Phase 2)Active Not RecruitingNCT05563844
What this trial is testing

Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

Who this might be right for
Diffuse Large B Cell Lymphoma，DLBCL
Chengdu Zenitar Biomedical Technology Co., Ltd 74
Not applicableStudy completedNCT01609179
What this trial is testing

IPI-926 Extension Protocol for Continuation of Treatment With IPI-926

Who this might be right for
Basal Cell CarcinomaChondrosarcoma
Infinity Pharmaceuticals, Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT04625907
What this trial is testing

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Who this might be right for
Rhabdomyosarcoma
University of Birmingham 1,672
Testing effectiveness (Phase 2)UnknownNCT04480502
What this trial is testing

ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

Who this might be right for
Undifferentiated Pleomorphic SarcomaMyxofibrosarcoma
Tracon Pharmaceuticals Inc. 207
Not applicableStudy completedNCT05236257
What this trial is testing

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database

Who this might be right for
Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene FusionInfantile Fibrosarcoma
Bayer 93
Testing effectiveness (Phase 2)Looking for participantsNCT07252739
What this trial is testing

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 140
Not applicableLooking for participantsNCT04557969
What this trial is testing

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

Who this might be right for
Gastric CancerGastric NeoplasmGastrointestinal Stromal Sarcoma+2 more
National Cancer Institute (NCI) 400
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Not applicableLooking for participantsNCT07778212
What this trial is testing

Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaIntermediate-High RiskFirst-Line
The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)UnknownNCT03570437
What this trial is testing

Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?

Who this might be right for
CarcinosarcomaEndometrial Neoplasms
University of Manchester 124
Next Page